Xazb Supply Veterinary Pharmaceutical API Enrofloxacin HCl/Enrofloxacin Hydrochloride Powder

• Type: Veterinary X Machine
• Syringe: Plastic Syringe
• Blood Sampling Needle: Ordinary Tube
• Shipping Cost: Estimated freight per unit.: about shipping cost and estimated delivery time.
• Currency: US$
• Return&refunds: You can apply for a refund up to 30 days after receipt of the products.
• Model NO.: Enrofloxacin
• Breathing Pattern: Auto-Control
• Animal Anesthesia Machine Control Method: Pneumatic
• Transport Package: Foil Bag
• Specification: 99%
• Trademark: XAZB
• Origin: China
• Production Capacity: 1000mt/Year
• Package Size: 30.00cm * 40.00cm * 30.00cm
• Package Gross Weight: 1.500kg
• Lead Time: 1 days (1 - 10 kg) ; 3 days (11 - 100 kg) ; To be negotiated ( > 100 kg)

Product Description

Veterinary Pharmaceutical API Enrofloxacin HCl/Enrofloxacin Hydrochloride Powder

 

_{Enrofloxacin base 
CAS: 93106-60-6
MF:  C19H22FN3O3  
Purity: 99% min
Melting range:  221ºC~226ºC  
Enrofloxacin Hcl ,112732-17-9
Quality standard :CPV2010 /USP/EP/BP
Use:Veterinary medicine 
Fluoroquinolonic acid::  ≤0.2%  
Appearance: Light-yellow or light-yellow orange crystalline powder
 Veterinary Pharmaceutical API Enrofloxacin HCl/Enrofloxacin Hydrochloride Powder}

Enrofloxacin HCL is a broad spectrum bactericidal drugs, have special effects on mycoplasma. White on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect.

Enrofloxacin HCL is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Cattle:
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Pigs:
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.